Table 1. Gene Therapy in CNS Disorder Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Gene Therapy in CNS Disorder Market Restraints

Table 3. Gene Therapy in CNS Disorder Market Trends

Table 4. Gene Therapy in CNS Disorder Industry Policy

Table 5. Global Gene Therapy in CNS Disorder Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Gene Therapy in CNS Disorder Revenue Market Share by Company (2018-2023)

Table 7. Global Gene Therapy in CNS Disorder Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Gene Therapy in CNS Disorder Mergers & Acquisitions, Expansion Plans

Table 9. Global Gene Therapy in CNS Disorder Manufacturers Product Type

Table 10. China Gene Therapy in CNS Disorder Revenue by Company (2018-2023) & (US$ million)

Table 11. China Gene Therapy in CNS Disorder Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Gene Therapy in CNS Disorder Upstream (Raw Materials)

Table 13. Global Gene Therapy in CNS Disorder Typical Customers

Table 14. Gene Therapy in CNS Disorder Typical Distributors

Table 15. By Type, Global Gene Therapy in CNS Disorder Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Gene Therapy in CNS Disorder Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Gene Therapy in CNS Disorder Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Gene Therapy in CNS Disorder Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Gene Therapy in CNS Disorder Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Gene Therapy in CNS Disorder Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Gene Therapy in CNS Disorder Revenue Market Share, 2018-2029

Table 22. Voyager Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 23. Voyager Therapeutics Company Profile and Main Business

Table 24. Voyager Therapeutics Gene Therapy in CNS Disorder Models, Specifications and Application

Table 25. Voyager Therapeutics Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023

Table 26. Voyager Therapeutics Recent Developments

Table 27. Spark Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 28. Spark Therapeutics Company Profile and Main Business

Table 29. Spark Therapeutics Gene Therapy in CNS Disorder Models, Specifications and Application

Table 30. Spark Therapeutics Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023

Table 31. Spark Therapeutics Recent Developments

Table 32. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 33. Novartis AG Company Profile and Main Business

Table 34. Novartis AG Gene Therapy in CNS Disorder Models, Specifications and Application

Table 35. Novartis AG Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023

Table 36. Novartis AG Recent Developments

Table 37. Bluebird Bio Inc. Company Information, Head Office, Market Area and Industry Position

Table 38. Bluebird Bio Inc. Company Profile and Main Business

Table 39. Bluebird Bio Inc. Gene Therapy in CNS Disorder Models, Specifications and Application

Table 40. Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023

Table 41. Bluebird Bio Inc. Recent Developments

Table 42. Biogen Company Information, Head Office, Market Area and Industry Position

Table 43. Biogen Company Profile and Main Business

Table 44. Biogen Gene Therapy in CNS Disorder Models, Specifications and Application

Table 45. Biogen Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023

Table 46. Biogen Recent Developments

List of Figure

Figure 1. Gene Therapy in CNS Disorder Picture

Figure 2. Global Gene Therapy in CNS Disorder Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Gene Therapy in CNS Disorder Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Gene Therapy in CNS Disorder Market Share of Global

Figure 5. Global Gene Therapy in CNS Disorder Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Gene Therapy in CNS Disorder Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Gene Therapy in CNS Disorder Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Gene Therapy in CNS Disorder Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Gene Therapy in CNS Disorder Industry Chain

Figure 10. Viral Gene Therapy

Figure 11. Non-viral Gene Therapy

Figure 12. By Type, Global Gene Therapy in CNS Disorder Revenue, 2018-2029, US$ Million

Figure 13. By Type, Global Gene Therapy in CNS Disorder Revenue Market Share, 2018-2029

Figure 14. Alzheimer's Disease

Figure 15. Huntington's Disease

Figure 16. Parkinson's Disease

Figure 17. Batten Disease

Figure 18. By Application, Global Gene Therapy in CNS Disorder Revenue, 2018-2029, US$ Million

Figure 19. By Application, Global Gene Therapy in CNS Disorder Revenue Market Share, 2018-2029

Figure 20. By Region, Global Gene Therapy in CNS Disorder Revenue Market Share, 2018-2029

Figure 21. North America Gene Therapy in CNS Disorder Revenue & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Gene Therapy in CNS Disorder Revenue Market Share, 2018-2023

Figure 23. Europe Gene Therapy in CNS Disorder Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Gene Therapy in CNS Disorder Revenue Market Share, 2018-2023

Figure 25. Asia Pacific Gene Therapy in CNS Disorder Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Gene Therapy in CNS Disorder Revenue Market Share, 2018-2023

Figure 27. South America Gene Therapy in CNS Disorder Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Gene Therapy in CNS Disorder Revenue Market Share, 2018-2023

Figure 29. Middle East & Africa Gene Therapy in CNS Disorder Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)

Figure 31. By Company, U.S. Gene Therapy in CNS Disorder Market Share, 2018-2023

Figure 32. By Type, U.S. Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 34. Europe Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)

Figure 35. By Company, Europe Gene Therapy in CNS Disorder Market Share, 2018-2023

Figure 36. By Type, Europe Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 37. By Application, Europe Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 38. China Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)

Figure 39. By Company, China Gene Therapy in CNS Disorder Market Share, 2018-2023

Figure 40. By Type, China Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 41. By Application, China Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 42. Japan Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)

Figure 43. By Company, Japan Gene Therapy in CNS Disorder Market Share, 2018-2023

Figure 44. By Type, Japan Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 45. By Application, Japan Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 46. South Korea Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)

Figure 47. By Company, South Korea Gene Therapy in CNS Disorder Market Share, 2018-2023

Figure 48. By Type, South Korea Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 49. By Application, South Korea Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 50. Southeast Asia Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)

Figure 51. By Company, Southeast Asia Gene Therapy in CNS Disorder Market Share, 2018-2023

Figure 52. By Type, Southeast Asia Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 53. By Application, Southeast Asia Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 54. India Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)

Figure 55. By Company, India Gene Therapy in CNS Disorder Market Share, 2018-2023

Figure 56. By Type, India Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 57. By Application, India Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 58. Middle East & Asia Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)

Figure 59. By Company, Middle East & Asia Gene Therapy in CNS Disorder Market Share, 2018-2023

Figure 60. By Type, Middle East & Asia Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 61. By Application, Middle East & Asia Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches